Recombinant multi-species HNRNPA2B1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine HNRNPA2B1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene belongs to the A/B subfamily of ubiquitously expressed heterogeneous nuclear ribonucleoproteins (hnRNPs). The hnRNPs are RNA binding proteins and they complex with heterogeneous nuclear RNA (hnRNA). These proteins are associated with pre-mRNAs in the nucleus and appear to influence pre-mRNA processing and other aspects of mRNA metabolism and transport. While all of the hnRNPs are present in the nucleus, some seem to shuttle between the nucleus and the cytoplasm. The hnRNP proteins have distinct nucleic acid binding properties. The protein encoded by this gene has two repeats of quasi-RRM domains that bind to RNAs. This gene has been described to generate two alternatively spliced transcript variants which encode different isoforms. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 9130414A06Rik,HNRNPA2,HNRNPA2B1,HNRNPB1,HNRPA2,HNRPA2B1,HNRPB1,Heterogeneous nuclear ribonucleoproteins A2/B1,Hnrnpa2b1,Hnrpa2,Hnrpa2b1,IBMPFD2,OPMD2,RNPA2,SNRPB1,hnRNP,hnRNP A2/B1,hnrnp-A

Target products collectionGo to HNRNPA2B1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE1481-Ag-1/ GM-Tg-hg-SE1481-Ag-2 Human HNRNPA2B1 protein Human
GM-Tg-rg-SE1481-Ag-1/ GM-Tg-rg-SE1481-Ag-2 Rat HNRNPA2B1 protein Rat
GM-Tg-mg-SE1481-Ag-1/ GM-Tg-mg-SE1481-Ag-2 Mouse HNRNPA2B1 protein Mouse
GM-Tg-cynog-SE1481-Ag-1/ GM-Tg-cynog-SE1481-Ag-2 Cynomolgus/Rhesus macaque HNRNPA2B1 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE1481-Ag-1/ GM-Tg-felg-SE1481-Ag-2 Feline HNRNPA2B1 protein Feline
GM-Tg-cang-SE1481-Ag-1/ GM-Tg-cang-SE1481-Ag-2 Canine HNRNPA2B1 protein Canine
GM-Tg-bovg-SE1481-Ag-1/ GM-Tg-bovg-SE1481-Ag-2 Bovine HNRNPA2B1 protein Bovine
GM-Tg-equg-SE1481-Ag-1/ GM-Tg-equg-SE1481-Ag-2 Equine HNRNPA2B1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE1481-Ag-1/ GM-Tg-hg-SE1481-Ag-2; GM-Tg-rg-SE1481-Ag-1/ GM-Tg-rg-SE1481-Ag-2;
GM-Tg-mg-SE1481-Ag-1/ GM-Tg-mg-SE1481-Ag-2; GM-Tg-cynog-SE1481-Ag-1/ GM-Tg-cynog-SE1481-Ag-2;
GM-Tg-felg-SE1481-Ag-1/ GM-Tg-felg-SE1481-Ag-2; GM-Tg-cang-SE1481-Ag-1/ GM-Tg-cang-SE1481-Ag-2;
GM-Tg-bovg-SE1481-Ag-1/ GM-Tg-bovg-SE1481-Ag-2; GM-Tg-equg-SE1481-Ag-1/ GM-Tg-equg-SE1481-Ag-2
Products Name HNRNPA2B1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name HNRNPA2B1
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine HNRNPA2B1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.